This program has been designed by pharmacists, for pharmacists to cover the latest information you need to know about COVID-19, including: outpatient therapies, national and provincial guidelines, eligibility criteria, and how to mitigate the risk of any drug-drug interactions.
Aaron Sihota is a Primary Care Pharmacist at the UPCC Vancouver and Clinical Instructor at the UBC Faculty of Pharmaceutical Sciences. He is currently leading the development of a national Canadian consensus peer-reviewed publication for COVID-19 testing guidance for pharmacists with a pan-Canadian multidisciplinary Faculty bringing together pharmacists and infectious disease specialists.
Dr. Daniel J.G. Thirion.
Dr. Thirion is clinical professor in pharmacotherapy of infectious diseases in the Faculty of Pharmacy at l’Université de Montréal. He is also founder of the infectious diseases and antimicrobial stewardship program at McGill University. He holds a Doctorate in Pharmacy from Wayne State University, completed a post-doctoral fellowship at the University of California in San Francisco, and is a Fellow of the Canadian Society of Hospital Pharmacists.
Upon completion of this activity, participants will be able to:
1. Describe the role of pharmacists in the outpatient treatment of COVID-19
2. Explain the mechanism of action, efficacy and safety of available outpatient therapies for COVID-19
3. Apply national and provincial guidelines for the outpatient treatment of COVID-19
4. Identify patients eligible for different outpatient therapies based on risk stratification
5. Identify and manage drug-drug interactions